16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Exploring social harms during distribution of HIV self‐testing kits using mixed‐methods approaches in Malawi

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          HIV self‐testing (HIVST) provides couples and individuals with a discreet, convenient and empowering testing option. As with all HIV testing, potential harms must be anticipated and mitigated to optimize individual and public health benefits. Here, we describe social harms (SHs) reported during HIVST implementation in Malawi, and propose a framework for grading and responding to harms, according to their severity.

          Methods

          We report findings from six HIVST implementation studies in Malawi (2011 to 2017) that included substudies investigating SH reports. Qualitative methods included focus group discussions, in‐depth interviews and critical incident interviews. Earlier studies used intensive quantitative methods (post‐test questionnaires for intimate partner violence, household surveys, investigation of all deaths in HIVST communities). Later studies used post‐marketing reporting with/without community engagement. Pharmacovigilance methodology (whereby potentially life‐threatening/changing events are defined as “serious”) was used to grade SH severity, assuming more complete passive reporting for serious events.

          Results

          During distribution of 175,683 HIVST kits, predominantly under passive SH reporting, 25 serious SHs were reported from 19 (0.011%) self‐testers, including 15 partners in eight couples with newly identified HIV discordancy, and one perinatally infected adolescent. There were no deaths or suicides. Marriage break‐up was the most commonly reported serious SH (sixteen individuals; eight couples), particularly among serodiscordant couples. Among new concordant HIV‐positive couples, blame and frustration was common but rarely (one episode) led to serious SHs. Among concordant HIV‐negative couples, increased trust and stronger relationships were reported. Coercion to test or disclose was generally considered “well‐intentioned” within established couples. Women felt empowered and were assertive when offering HIVST test kits to their partners. Some women who persuaded their partner to test, however, did report SHs, including verbal or physical abuse and economic hardship.

          Conclusions

          After more than six years of large‐scale HIVST implementation and in‐depth investigation of SHs in Malawi, we identified approximately one serious reported SH per 10,000 HIVST kits distributed, predominantly break‐up of married serodiscordant couples. Both “active” and “passive” reporting systems identified serious SH events, although with more complete capture by “active” systems. As HIVST is scaled‐up, efforts to support and further optimize community‐led SH monitoring should be prioritized alongside HIVST distribution.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          Under-reporting of adverse drug reactions : a systematic review.

          The purpose of this review was to estimate the extent of under-reporting of adverse drug reactions (ADRs) to spontaneous reporting systems and to investigate whether there are differences between different types of ADRs. A systematic literature search was carried out to identify studies providing a numerical estimate of under-reporting. Studies were included regardless of the methodology used or the setting, e.g. hospital versus general practice. Estimates of under-reporting were either extracted directly from the published study or calculated from the study data. These were expressed as the percentage of ADRs detected from intensive data collection that were not reported to the relevant local, regional or national spontaneous reporting systems. The median under-reporting rate was calculated across all studies and within subcategories of studies using different methods or settings. In total, 37 studies using a wide variety of surveillance methods were identified from 12 countries. These generated 43 numerical estimates of under-reporting. The median under-reporting rate across the 37 studies was 94% (interquartile range 82-98%). There was no significant difference in the median under-reporting rates calculated for general practice and hospital-based studies. Five of the ten general practice studies provided evidence of a higher median under-reporting rate for all ADRs compared with more serious or severe ADRs (95% and 80%, respectively). In comparison, for five of the eight hospital-based studies the median under-reporting rate for more serious or severe ADRs remained high (95%). The median under-reporting rate was lower for 19 studies investigating specific serious/severe ADR-drug combinations but was still high at 85%. This systematic review provides evidence of significant and widespread under-reporting of ADRs to spontaneous reporting systems including serious or severe ADRs. Further work is required to assess the impact of under-reporting on public health decisions and the effects of initiatives to improve reporting such as internet reporting, pharmacist/nurse reporting and direct patient reporting as well as improved education and training of healthcare professionals.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes.

            This paper synthesizes the rates, barriers, and outcomes of HIV serostatus disclosure among women in developing countries. We identified 17 studies from peer-reviewed journals and international conference abstracts--15 from sub-Saharan Africa and 2 from south-east Asia--that included information on either the rates, barriers or outcomes of HIV serostatus disclosure among women in developing countries. The rates of disclosure reported in these studies ranged from 16.7% to 86%, with women attending free-standing voluntary HIV testing and counselling clinics more likely to disclose their HIV status to their sexual partners than women who were tested in the context of their antenatal care. Barriers to disclosure identified by the women included fear of accusations of infidelity, abandonment, discrimination and violence. Between 3.5% and 14.6% of women reported experiencing a violent reaction from a partner following disclosure. The low rates of HIV serostatus disclosure reported among women in antenatal settings have several implications for prevention of mother-to-child transmission of HIV (pMTCT) programmes as the optimal uptake and adherence to such programmes is difficult for women whose partners are either unaware or not supportive of their participation. This article discusses these implications and offers some strategies for safely increasing the rates of HIV status disclosure among women.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Three techniques for integrating data in mixed methods studies.

                Bookmark

                Author and article information

                Contributors
                kumwenda@gmail.com
                Journal
                J Int AIDS Soc
                J Int AIDS Soc
                10.1002/(ISSN)1758-2652
                JIA2
                Journal of the International AIDS Society
                John Wiley and Sons Inc. (Hoboken )
                1758-2652
                25 March 2019
                March 2019
                : 22
                : Suppl Suppl 1 , Realizing the potential of HIV self‐testing for Africa: lessons learned from the STAR project, Guest Editors: Vincent J Wong, Nathan Ford, Kawango Agot ( doiID: 10.1002/jia2.2019.22.issue-S1 )
                : e25251
                Affiliations
                [ 1 ] Malawi Liverpool Wellcome Trust Clinical Research Programme Blantyre Malawi
                [ 2 ] Helse Nord TB Initiative College of Medicine University of Malawi Blantyre Malawi
                [ 3 ] HIV and Global Hepatitis Department World Health Organization Geneva Switzerland
                [ 4 ] Clinical Research Department London School of Hygiene and Tropical Medicine London UK
                [ 5 ] Department of International Public Health Liverpool School of Tropical Medicine Liverpool UK
                [ 6 ] Population Services International Lilongwe Malawi
                [ 7 ] Ministry of Health Lilongwe Malawi
                [ 8 ] Population Services International Johannesburg South Africa
                Author notes
                [*] [* ] Corresponding author: Moses K Kumwenda, Malawi Liverpool Wellcome Trust Clinical Research Programme, P.O. Box 30096, Chichiri, Blantyre 3, Malawi. Tel: +265 999 981 677. ( kumwenda@ 123456gmail.com )
                Author information
                https://orcid.org/0000-0003-3091-7330
                https://orcid.org/0000-0001-6095-9430
                https://orcid.org/0000-0002-5117-3732
                Article
                JIA225251
                10.1002/jia2.25251
                6432111
                30907508
                602bb668-1029-4dbe-a0f8-86770945cf3a
                © 2019 World Health Organization; licensed by IAS.

                This is an open access article distributed under the terms of the Creative Commons Attribution IGO License https://creativecommons.org/licenses/by/3.0/igo/legalcode which permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or the article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article’s URL.

                History
                : 10 May 2018
                : 24 January 2019
                Page count
                Figures: 1, Tables: 5, Pages: 18, Words: 12258
                Funding
                Funded by: Wellcome Trust
                Award ID: WT200901
                Award ID: 105828/Z/14/Z
                Funded by: Unitaid
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                jia225251
                March 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.1 mode:remove_FC converted:25.03.2019

                Infectious disease & Microbiology
                hiv/aids,hiv self‐test,hiv testing,social harms,malawi
                Infectious disease & Microbiology
                hiv/aids, hiv self‐test, hiv testing, social harms, malawi

                Comments

                Comment on this article